Literature DB >> 1314359

Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System.

K Syrjänen1, V Kataja, M Yliskoski, F Chang, S Syrjänen, S Saarikoski.   

Abstract

The newly introduced Bethesda System proposes to replace the terms dysplasia, carcinoma in situ (CIS), or cervical intraepithelial neoplasia (CIN) with two terms, low-grade squamous intraepithelial lesion (SIL) or high-grade SIL. We tested the biologic relevance of the Bethesda System (ie, its ability to establish a close correlation between biologic behavior and the different grades of lesions) in a series of 528 women with genital human papillomavirus (HPV)-associated precancerous lesions prospectively followed for 10 years. The cervical biopsies were reclassified as either low-grade or high-grade SIL, and the data obtained by colposcopy, Papanicolaou smear, and HPV typing, as well as the biological behavior of the lesions, were analyzed in these two groups. Altogether, 77.4% (376 of 486) of the lesions were classified as low-grade SIL lesions; the rest (22.6%) belonged to the high-grade SIL category. In the low-grade SIL category, 46.8% of the women were 24 years old or younger, as compared with 37.3% in the high-grade SIL group. The colposcopic appearance was normal significantly more frequently in the low-grade SIL lesions (22.1%) than in the high-grade category (8.5%) (P less than .001). A single Papanicolaou smear was inadequate to distinguish between low-grade and high-grade SIL, as evidenced by almost identical distributions of Papanicolaou smear class I and II cells in both categories. Noteworthy was the discovery of normal Papanicolaou smears in 8.2% of the high-grade SIL lesions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314359

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

1.  Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia.

Authors:  Divya A Patel; Laura S Rozek; Justin A Colacino; Adrienne Van Zomeren-Dohm; Mack T Ruffin; Elizabeth R Unger; Dana C Dolinoy; David C Swan; Juanita Onyekwuluje; Cecilia R DeGraffinreid; Electra D Paskett
Journal:  J Virol Methods       Date:  2012-06-01       Impact factor: 2.014

2.  Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Charles Wibbelsman; Teresa M Darragh; Adaleen Powers; Sepideh Farhat; Stephen Shiboski
Journal:  Obstet Gynecol       Date:  2010-12       Impact factor: 7.661

Review 3.  Conservative management of adolescents with abnormal cytology and histology.

Authors:  Anna-Barbara Moscicki
Journal:  J Natl Compr Canc Netw       Date:  2008-01       Impact factor: 11.908

Review 4.  Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.

Authors:  Lea E Widdice; Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-07-23       Impact factor: 5.012

5.  Epithelial-mesenchymal transition in cervical carcinoma.

Authors:  Mei-Yi Lee; Meng-Ru Shen
Journal:  Am J Transl Res       Date:  2012-01-01       Impact factor: 4.060

6.  Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.

Authors:  Shao-Ming Wang; Danny Colombara; Ju-Fang Shi; Fang-Hui Zhao; Jing Li; Feng Chen; Wen Chen; Shu-Min Li; Xun Zhang; Qin-Jing Pan; Jerome L Belinson; Jennifer S Smith; You-Lin Qiao
Journal:  Int J Gynecol Cancer       Date:  2013-05       Impact factor: 3.437

7.  Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Authors:  C Hankins; F Coutlée; N Lapointe; P Simard; T Tran; J Samson; L Hum
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

8.  Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Charles Wibbelsman; Adaleen Powers; Teresa M Darragh; Sepideh Farhat; Ruth Shaber; Stephen Shiboski
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.661

Review 9.  Management of adolescents who have abnormal cytology and histology.

Authors:  Anna-Barbara Moscicki
Journal:  Obstet Gynecol Clin North Am       Date:  2008-12       Impact factor: 2.844

10.  Polymerase chain reaction-assisted papillomavirus detection in cervicovaginal smears: stratification by clinical risk and cytology reports.

Authors:  C Kühler-Obbarius; K Milde-Langosch; G Helling-Giese; A Salfelder; C Peimann; T Löning
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.